Novel genetic and epigenetic alterations in ... - Ous-research.no

Novel genetic and epigenetic alterations in ... - Ous-research.no Novel genetic and epigenetic alterations in ... - Ous-research.no

ous.research.no
from ous.research.no More from this publisher
11.07.2015 Views

Introductioninasmuch as 80% of colorectal tumors [64]. Activation of the proto-oncogene KRAS is alsoconsidered an early event, and is present in 35% of colorectal carcinomas ** . TP53, called “theguardian of the genome”[66] is a critical component in sensing DNA damage and stresssignals, and is the most frequently altered tumor suppressor gene in human cancer in general.In colorectal cancer it is not altered until late in the development, in advanced carcinomas,and close to 50% of all CRC have mutations in TP53 at this stage †† . According to this model,microsatellite instability is a late event as it is only seen in advanced adenomas andsubsequent stages[64].Compelling evidence in recent years have questioned this paradigm and turned the scaletowards adenomas giving rise only to chromosome instable and CIMP-negative tumors,while the previously “ignored” hyperplastic polyps (HPs) have re-established their malignantpotential, as a subgroup of these, the sessile serrated polyps, are likely to give rise to MSI andCIMP tumors[67-70]. An equivalent to the adenoma-carcinoma sequence has now beensuggested and includes the development from normal mucosa via HPs and serrated lesionsto MSI-carcinomas. Typical for these cancers is that mutation in the proto-oncogene BRAFis considered the “gatekeeper”, and that the dysregulation of the methylation machineryoccurs before microsatellite instability (Figure 10)[71].Hypermethylation in normal-appearing colorectal mucosa adjacent to the primary tumorshas gained interest lately. This abnormality is thought to be the initiating event intumorigenesis, as it presents a field in which the cells are especially susceptible for additionalalterations. With a sufficing amount of alterations, the tumorigenesis is initiated. Thisphenomenon is called “field effect” or “field cancerization”, and several genes have beensuggested to generate such[72-75].** Catalogue of Somatic Mutations in Cancer database – http://www.sanger.ac.uk/genetics/CGP/cosmic/†† IARC TP53 Mutation Database (Release 12) - http://www-p53.iarc.fr/26

IntroductionFigure 10. Molecular pathways to colorectal cancer. Colorectal cancer develops through several distincthistopathological steps, each of which is associated with different kind of alterations. It is now believed thatMSI (in red) and CIN tumors (in blue) develop through two distinct pathways, the sessile serrated pathway,giving rise to MSI-tumors in the proximal colon, and the traditional adenoma-carcinoma pathway, giving rise toCIN tumors in the distal colon. While APC is considered to be the initiating event in the initiating event forCIN tumors, BRAF is one of the earliest recognized changes among the MSI precursors. The geneticcomplexity increases throughout CIN tumorigenesis due to the chromosomal instability, while CIMP leads toepigenetic instability among the MSI precursors, eventually affecting MLH1, which then causes MSI. With MSI,genes carrying repetitive units within their coding region are especially susceptible for mutations.27

Introduction<strong>in</strong>asmuch as 80% of colorectal tumors [64]. Activation of the proto-oncogene KRAS is alsoconsidered an early event, <strong>and</strong> is present <strong>in</strong> 35% of colorectal carc<strong>in</strong>omas ** . TP53, called “theguardian of the ge<strong>no</strong>me”[66] is a critical component <strong>in</strong> sens<strong>in</strong>g DNA damage <strong>and</strong> stresssignals, <strong>and</strong> is the most frequently altered tumor suppressor gene <strong>in</strong> human cancer <strong>in</strong> general.In colorectal cancer it is <strong>no</strong>t altered until late <strong>in</strong> the development, <strong>in</strong> advanced carc<strong>in</strong>omas,<strong>and</strong> close to 50% of all CRC have mutations <strong>in</strong> TP53 at this stage †† . Accord<strong>in</strong>g to this model,microsatellite <strong>in</strong>stability is a late event as it is only seen <strong>in</strong> advanced ade<strong>no</strong>mas <strong>and</strong>subsequent stages[64].Compell<strong>in</strong>g evidence <strong>in</strong> recent years have questioned this paradigm <strong>and</strong> turned the scaletowards ade<strong>no</strong>mas giv<strong>in</strong>g rise only to chromosome <strong>in</strong>stable <strong>and</strong> CIMP-negative tumors,while the previously “ig<strong>no</strong>red” hyperplastic polyps (HPs) have re-established their malignantpotential, as a subgroup of these, the sessile serrated polyps, are likely to give rise to MSI <strong>and</strong>CIMP tumors[67-70]. An equivalent to the ade<strong>no</strong>ma-carc<strong>in</strong>oma sequence has <strong>no</strong>w beensuggested <strong>and</strong> <strong>in</strong>cludes the development from <strong>no</strong>rmal mucosa via HPs <strong>and</strong> serrated lesionsto MSI-carc<strong>in</strong>omas. Typical for these cancers is that mutation <strong>in</strong> the proto-oncogene BRAFis considered the “gatekeeper”, <strong>and</strong> that the dysregulation of the methylation mach<strong>in</strong>eryoccurs before microsatellite <strong>in</strong>stability (Figure 10)[71].Hypermethylation <strong>in</strong> <strong>no</strong>rmal-appear<strong>in</strong>g colorectal mucosa adjacent to the primary tumorshas ga<strong>in</strong>ed <strong>in</strong>terest lately. This ab<strong>no</strong>rmality is thought to be the <strong>in</strong>itiat<strong>in</strong>g event <strong>in</strong>tumorigenesis, as it presents a field <strong>in</strong> which the cells are especially susceptible for additional<strong>alterations</strong>. With a suffic<strong>in</strong>g amount of <strong>alterations</strong>, the tumorigenesis is <strong>in</strong>itiated. Thisphe<strong>no</strong>me<strong>no</strong>n is called “field effect” or “field cancerization”, <strong>and</strong> several genes have beensuggested to generate such[72-75].** Catalogue of Somatic Mutations <strong>in</strong> Cancer database – http://www.sanger.ac.uk/<strong>genetic</strong>s/CGP/cosmic/†† IARC TP53 Mutation Database (Release 12) - http://www-p53.iarc.fr/26

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!